Quality control guidelines for MIC susceptibility testing of omiganan pentahydrochloride (MBI 226), a novel antimicrobial peptide.
Tamara R
TR
Anderegg
Thomas R
TR
Fritsche
Ronald N
RN
Jones
D023181:Antimicrobial Cationic Peptides / Q000494:pharmacology*; D001419:Bacteria / Q000187:drug effects*; D017408:Guidelines as Topic; D008826:Microbial Sensitivity Tests / Q000592:standards*; D011785:Quality Assurance, Health Care; D015203:Reproducibility of Results; D015003:Yeasts / Q000187:drug effects
D023181:Antimicrobial Cationic Peptides; C478918:omiganan pentahydrochloride